The Government of Nigeria, with support from the World Health Organization (WHO), CDC, and Gavi, and the Vaccine Alliance will safely relaunch an accelerated series of mass preventive vaccination campaigns to protect
almost 30 million Nigerians against Yellow Fever.
The accelerated yellow fever campaign phase 4 will target more than 30 million people in 7 states (Bauchi, Benue, Borno, Delta, Osun, Ondo, and Oyo) and complete the pending 2019 phase 3 Yellow Fever campaign in Anambra state.
This will be followed by further Yellow Fever vaccination efforts between 2021-2022, which will target more than 95 million persons as part of the push to eliminate yellow fever epidemics.
The Executive Director, National Primary Health Care Development Agency, Dr Faisal Shuaib called on all eligible persons in the aforementioned states to go for vaccination.
He said Yellow fever outbreaks have re-emerged as a serious public health concern since September 2017.
“While COVID-19 remains a pressing priority, we are pleased to be able to safely relaunch life-protecting vaccination campaigns against yellow fever this week.
The upcoming campaigns will help stop outbreaks and save lives.”
“The 2020 campaigns represent an acceleration of the phased preventive mass vaccination campaign aimed to protect the country against yellow fever.”
The Managing Director for Country Programs at GAVI, Thabani Maphosa
disclosed that the Yellow fever vaccine confers lifelong protection, and is the most effective tool to prevent outbreaks of potentially deadly disease”.
“Gavi has been a long-time partner in this effort, and we are committed to continuing to support the Government of Nigeria and partners in their efforts to reach the millions, including children, who are at risk.”
The WHO Representative to Nigeria, Dr Kazadi Mulombo, added that through decisive and agile work by the WHO EPI and Health Emergency programmes, WHO has helped source and provide 265,000 face masks that will support safe implementation of life-saving yellow fever vaccination activities in the COVID-19 context in Anambra state.
“The technical support provided by WHO to National and State levels will ensure a high-quality campaign including planning, training of health care workers, supervision of the campaign and high vaccination coverage. ”
He gave assurance that the health bodies and partners are committed to ensuring that every person at-risk of yellow fever is protected.
To enable safe implementation in the COVID-19 context, personal protective equipment (PPE) and enhanced infection prevention control measures have been assured by a collaborative initiative and agile support of the State Ministries of Health, CDC, and World Health Organization (WHO) Health Emergencies Programme, and funding from Gavi, the Vaccine Alliance.
The 10-day YF campaign in Anambra is scheduled to kick off on the 16th of October while the phase 4 states are scheduled to start on the 20th of November 2020.
“These campaigns are to be implemented in accordance with the WHO guidelines for the implementation of mass campaigns in the context of the COVID-19 pandemic. with the use of PPEs and infection prevention control strategies as recommended.”
The acceleration has been endorsed by the global strategy to Eliminate Yellow Fever Epidemics (EYE) by 2026. Nigeria is a priority country for the EYE Strategy.
Yellow fever is a viral infection transmitted by infected mosquitos. The infection can cause serious disease, including fever and jaundice (yellowness of the eyes) and can even lead to death.